Metabolic and toxicological considerations of Bruton ’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma

Volume 20, Issue 4, April 2024, Page 207-224 .

Source: Expert Opinion on Drug Metabolism and Toxicology - March 25, 2024 Category: Drugs & Pharmacology Authors: Anna Wolska-WasherPawe ł RobakMagdalena WitkowskaTadeusz Robaka Department of Hematology, Medical University of Lodz, Lodz, Polandb Department of Hematooncology, Copernicus Memorial Hospital, Lodz, Polandc Department of General Hematology, Copernicus Mem Source Type: research